Combination therapy for cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/00 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01)

Patent

CA 2542327

Anti-hormonal (anti-estrogenic steriod) therapy and immunotherapy are used in combination to treat breast cancer. The preferred immunotherapeutic agent is an immunogen, preferably comprising sialyl-tn, and more preferably is a sialyl -Tn/KLH conjugate.

La présente invention concerne une thérapie anti-hormonale (stéroïde anti-oestrogénique) et une immunothérapie qui sont utilisées de manière combinée pour traiter le cancer du sein. L'agent immunothérapeutique privilégié est un immunogène, de préférence, il comprenant du sialyl-Tn, et, mieux encore, cet agent est un conjugué sialyl -Tn/KLH.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy for cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1723773

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.